|
Medical network - on February 24, the Chinese government will introduce a national plan to pharmaceutical intermediate, is expected to cut more than half of the pharmaceutical companies, but experts say, the government wants to achieve the goal of reducing drug prices, solving medical bribery phenomenon is still very difficult.
The vast majority of China's $110 billion a year drugs from public hospitals, the hospital income source rely mainly on medicines and medical equipment. Chinese medicine sales network is complex, there are 13500 dealers to participate in, the doctor rebate phenomenon is widespread.
The state council, said last month that next year will be limited between drug companies and hospitals across the country the invoice number, implement of two votes. Drug dealers are expected to be so.
Xie, deputy secretary-general of the Chinese medical doctor association Qilin, according to the data from the aspects of government is: from 10000 to 10000-3000.
It is understood that the "two votes" reform plan has been in 11 provinces, China's eastern coastal fujian province, according to a report from 2012 since the implementation of the plan have dealers in half. Wu zhen, deputy chief of the state food and drug supervision and administration bureau said last year, the implementation of this policy is the cause of market concentration.
An overseas medical equipment manufacturers an unnamed employee said, "the agent does not expand perish." Economic observer reported that industry professionals in this field more than 3 million, many of whom will be forced to move to big company or a career change.
Corvington? Eric (something that law firm Covington & Burling) partners said in a recent report by the Carlson, reduce small dealers will accelerate industry consolidation, the resource "concentrated in the hands of individual pharmaceutical distributors, they many are state-owned or state-controlled enterprises".
The plan of beneficiary including national medicine group, the Chinese government has its majority stake, fosun medicine and its partners.
This reform for Chinese pharmaceutical companies will form a huge challenge, they used to sell drugs is through local intermediaries indirect. If such reform medical equipment market, will reduce the complex supply chain requirements, good for overseas enterprises.
For example: Ireland medtronic by Chinese antitrust authorities last year because of its limit fines of up to $17 million in local multi-layer distribution system. Other large multinational companies often have their own sales team, according to industry observers Rachel Lee, according to the sales staff of 20000 people in 2011.
But direct sales personnel strategy has failed to put an end to bribery. GSK 2014 sales staff was sent off after being found guilty of corruption for 297 million pounds; On suspicion of bribery and bristol-myers squibb company China hospital officials in the United States faces a $14 million fine; Novartis last year also pay $25 million for similar charges.
Chinese government officials said that the purpose of reform is to reduce drug prices. McKinsey & company of medical Franck Le Deu believes that the current drug distribution system "very inefficient, and cost is high, and the final is to pay by the patients. Cities can develop local dealers benefit ourselves."
But Liu, a researcher at tsinghua university hospital reform Tingfang believed that fewer dealers to pharmaceutical companies far outweigh the benefits of patients, because doing so save the distribution cost. He said, "drug prices will not have much impact. Rebate is still there. It is necessary to adjust the doctor salary", because the hospital low-income workers still hope that the sales commission. |
